Anti-FN1 (Radretumab)-MC-MMAF ADC
This ADC product is comprised of an anti-FN1 nanobody conjugated via a MC linker to MMAF. The MMAF is targeted to ceRoom Temperatureain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAF binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.
Product Specifications
CAS Number
9007-83-4
Format
Solution
Shipping Conditions
Ice Packs
Storage Conditions
-20°C
More Discoveries
Explore Other Products
Browse additional items from our catalog
339537-01 50 µL
VIPR1 (Vasoactive intestinal Polypeptide Receptor 1, VIP-R-1, Pituitary Adenylate Cyclase-activating Polypeptide Type II Receptor, PACAP Type II Receptor, PACAP-R-2, PACAP-R2, VPAC1)
Sign In for Pricing
View Details 
339537-02 100 µL
VIPR1 (Vasoactive intestinal Polypeptide Receptor 1, VIP-R-1, Pituitary Adenylate Cyclase-activating Polypeptide Type II Receptor, PACAP Type II Receptor, PACAP-R-2, PACAP-R2, VPAC1)
Sign In for Pricing
View Details 